Method and compositions for the genetic control of insect pests in cotton plants by chitin synthase gene silencing

Abstract

The present invention relates to the control of infestation of pests by inhibiting or reducing the expression of genes of the family of chitin synthase. The invention further provides methods and compositions for controlling pests by feeding them with one or more double-stranded RNA molecules provides by the present invention. The invention further describes a method of obtaining transgenic plants that express double-stranded RNA molecules. The present invention is preferably used for cotton-plants.

Claims

1. A chimeric gene, comprising: a) a nucleic acid molecule comprising a nucleic acid sequence entirely complementary to a nucleotide sequence having at least about 95% sequence identity to a sequence selected from the group consisting of: SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 and SEQ ID NO: 6; or b) a nucleic acid molecule comprising a first region and a second region which are transcribed into a ribonucleotide molecule, said first region comprising at least 23 contiguous nucleotides of a nucleic acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 and SEQ ID NO: 6, and said second region comprising a nucleotide sequence entirely complementary to said first region; and c) a heterologous active promoter, operatively linked to the nucleic acid molecule of a) or b); wherein ingestion by a coleopteran pest, of a ribonucleotide molecule transcribed from the nucleic acid molecule of a) or b), inhibits or reduces the proliferation of said pest.

2. A gene construct comprising one or more chimeric genes as defined in claim 1.

3. A gene construct according to claim 2, wherein said one or more chimeric genes comprise: (a) a first region comprising a nucleic acid sequence of at least 23 contiguous nucleotides, having at least 23 contiguous nucleotides of a sequence of sense nucleotides selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 and SEQ ID NO: 6; (b) a second region comprising a nucleotide sequence of about 23 contiguous nucleotides having at least 23 contiguous nucleotides of a sequence of sense nucleotides selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 and SEQ ID NO: 6.

4. The gene construct according to claim 3, wherein the first and the second region are capable of forming a double-stranded region, which may have, in addition to the total length of the first and of the second region, a spacing region between them containing at least about 3 nucleotides.

5. The gene construct according to claim 4, wherein the spacing sequence is an intron.

6. A vector characterized by comprising the chimeric gene according to claim 1.

7. The vector according to claim 6, wherein said vector promotes the expression of the molecule of interest or a fragment thereof.

8. A ribonucleotide molecule, characterized by being produced from the expression of the chimeric gene according to claim 1.

9. The ribonucleotide molecule according to claim 8, wherein said ribonucleotide molecule is a double-stranded ribonucleotide.

10. A transformed cell comprising the chimeric gene of claim 1.

11. The cell according to claim 10, wherein said cell is a prokaryotic cell.

12. The cell according to claim 10, wherein said cell is a eukaryotic cell.

13. The cell according to claim 10, wherein said cell is a plant or bacterial cell.

14. A transformed plant, characterized by comprising the chimeric gene of claim 1.

15. The plant according to claim 14, characterized in that the nucleic acid molecule is expressed in a plant cell, in the form of a double-stranded ribonucleotide sequence, and the ingestion of diet containing an inhibiting amount, to insect pest, of said double-stranded ribonucleotide sequence inhibits or reduces the proliferation of said pest.

16. The plant according to claim 15, wherein the insect pest is selected from the group consisting of Anthonomus grandis, Diabrotica virgifera, Tenebrio molitor, Tribolium castaneum and Hypothenemus hampei, Phoracantha semipunctata, Lixus angustatus, Acanthoscelides obtectus and other coleoptera that cause damages to woods and agronomically important plants of the families Scolytidae, Cerambycidae, Curculionidae and Bostrichida and other coleoptera.

17. A commercial product produced from a plant comprising the chimeric gene of claim 1, wherein said commercial product comprises a detectable amount of the chimeric gene of claim 1, or of a ribonucleotide expressed therefrom.

18. The ribonucleotide molecule according to claim 9, wherein the ingestion or assimilation, by coleopteran pest, of the double-stranded ribonucleotide, inhibits or reduces the proliferation of said pest.

19. A method for producing transgenic eukaryotic organisms, in which the expression of a target gene in the cells of the organism is reduced, said method comprising the steps of: I) inserting the chimeric gene of claim 1 into a cell or cells of the organism to produce a transgenic cell or cells; and II) growing or regenerating a transgenic eukaryotic organism of the transgenic cell or cells.

20. A method for controlling infestation of coleopterans, said method comprising supplying, in the diet of a coleopteran pest an agent comprising the chimeric gene according to claim 1, or the ribonucleotide molecule of claim 9.

21. The method according to claim 19, wherein the eukaryotic organism cell further comprises a polynucleotide sequence encoding a pesticidal agent.

22. The method according to claim 21, wherein the pesticidal agent is selected from the group consisting of patatin, an insecticidal protein of Bacillus thuringiensis, an insecticidal Xenorhabdus protein, an insecticidal Photorhabdus protein, an insecticidal Bacillus laterosporous protein, an insecticidal Bacillus sphaericus protein, enzymes of the family of chitinase and a lignin.

23. The method according to claim 19, wherein the coleopteran pest is selected from the group consisting of Anthonomus grandis, Diabrotica virgifera, Tenebrio molitor, Tribolium castaneum e Hypothenemus hampei, Phoracantha semipunctata, Lixus angustatus, Acanthoscelides obtectus and other coleopterans that cause damages to woods and agronomically important plants of the families Scolytidae, Cerambycidae, Curculionidae and Bostrichida and other coleopterans.

24. The method according to claim 19, wherein the actuation mode of the nucleic acid molecule or of the double-stranded ribonucleotide sequence, upon being ingested or assimilated by the pest, is that of suppression or reduction of the expression of a gene that performs a function that is essential to the survival of the insect.

25. The method according to claim 24, wherein the function essential to the survival of the insect is selected from the group of differentiation and development of the cuticle, formation of the egg, larval maturation, transition of larval stage, pupation, digestion and assimilation of nutrients, protection against pathogens.

26. A method for improving the yield of cultivated plants subject to infestation by insect pests, said method comprising the steps of: a. introducing the chimeric gene according to claim 1 into said plant; b. growing the plant obtained in step a so as to enable expression of said nucleic acid molecule, wherein this expression inhibits or reduces proliferation of said pests.

27. The method according to claim 26, wherein the expression of the nucleic acid molecule produces an RNA molecule that suppresses at least one first target gene in an insect pest that has ingested a portion of said plant, wherein said target gene performs at least one function that is essential to survival of the insect to be selected from the group of differentiation and development of cuticle, egg formation, larval maturation, larval stage transition, pupation, digestion and assimilation of nutrients, and protection against pathogens.

28. The method according to claim 27, wherein the insect pest is selected from the group consisting of Anthonomus grandis, Diabrotica virgifera, Tenebrio molitor, Tribolium castaneum and Hypothenemus hampei, Phoracantha semipunctata, Lixus angustatus, Acanthoscelides obtectus and other coleopterans that cause damages to woods and agronomically important plants of the families Scolytidae, Cerambycidae, Curculionidae and Bostrichida and other coleopterans.

29. A method for producing a commercial product, comprising obtaining the transformed plant as defined in claim 14 and preparing a commercial product from the transformed plant.

30. A method of producing a food or animal feed, comprising obtaining the transformed plant as defined in claim 14 and preparing a food or animal feed from said transformed plant.

31. A method for controlling infestation of coleopterans, characterized in that it comprises supplying, in the diet of a coleopteran pest an agent comprising the ribonucleotide sequence according to claim 8.

Description

BRIEF DESCRIPTION OF THE FIGURES

(1) The application file contains at least one drawing executed in color. Copies of this patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.

(2) FIG. 1Strategy of cloning the cDNA of AntgCHS1. The complete sequence of the cDNA of AntgCHS1 was determined by overlapping 3 PCR fragments.

(3) FIG. 2Strategy of cloning the cDNA of AntgCHS2. The complete sequence of the cDNA of AntgCHS2 was determined by overlapping 4 fragments of PCR products.

(4) FIG. 3Analysis of the relative expression of transcripts of AntgCHS1 in eggs of A. grandis by qPCR. actina and GAPDH were used as reference genes. The relative expression (UA) was calculated on the basis of the expression value for the treatment of dsRNA AntgCHS1, to which an arbitrary value of 1 was attributed. Different letters on the bars indicate a significant difference of the expression between the treatments based on two biological replicas (P<0.05, test-T). In the treatments of each insect was microinjected with 200 ng of dsRNA GUS (control) and 200 ng of dsRNA AntgCHS1.

(5) FIG. 4Effect of the dsRNA of AntgCHS1 on the oviposition of eggs of A. grandis. A. Effect of the dsRNA of AntgCHS1 on the viability of eggs of A. grandis; B. Unviable eggs from females microinjected with dsRNA de AntgCHS1. In the treatments, each insect was microinjected with 200 ng of dsRNA GUS (control) and 200 ng of dsRNA AntgCHS1.

(6) FIG. 5Effect of the dsRNA of AntgCHS1 on the newborn larvae from adult microinjected insects of A. grandis. A. Larvae from adult microinjected with dsRNA of AntgCHS1; B detail of a control larva from adults microinjected with dsRNA GUS (control), C and D detail of larvae of first instar with malformations in the cephalic capsule.

(7) FIG. 6Effect of dsRNA AntgCHS1 on the development of A. grandis. The microinjection of dsRNA AntgCHS1 was carried out on larvae of third instar. After microinjection the larvae were transferred to artificial diet to complete their development. After 10 days, the morphology of the insects was evaluated.

(8) FIG. 7Analysis of the relative expression of transcripts of AntgCHS2 after microinjection of different segments of dsRNA-genes of reference GAPDH and beta-actin 1. Control consisted in administering H2O; 2. dsRNA GUSconsisted in administering a dsRNA with the sequence of de 350 pb of the gene gus; 3. dsRNA AntgCHS2.1 (SEQ ID No 4); 4. dsRNA AntgCHS2.2 (SEQ ID No 5); 5. dsRNA AntgCHS2.3 (SEQ ID No 6).

(9) FIG. 8Analysis of the relative expression of transcript by PCR in real time of AntgCHS2 after microinjection of different concentrations of dsRNA AntgCHS2.3 (SEQ ID No 6) in adult insects of A. grandis after 48 hs.

(10) FIG. 9Analysis of the relative expression of transcripts by PCR in real time of AntgCHS2 after microinjection of different concentrations of dsRNA AntgCHS2.3 (SEQ ID No 6) in larvae of A. grandis after 72 hs.

(11) FIG. 10Analysis of persistence of the silencing of AntgCHS2 after the larval development of A. grandis by PCR in real time. The microinjection of dsRNA AntgCHS2.3 (SEQ ID No 6) was carried out in larvae and the silencing was analyzed on adult insects of A. grandis aps 72 hs from emergence.

(12) FIG. 11Effect of microinjection of dsRNA AntgCHS2.3 (SEQ ID No 6) on the oviposition of females of A. grandis. In the control treatment, one administered dsRNA GUS; AAnalysis of the amount of eggs/female/day; BAnalysis of the oviposition of the number of total eggs. In the treatments, each insect was microinjected with 200 ng of dsRNA GUS (control) and 200 ng of dsRNA AntgCHS2.3.

(13) FIG. 12Effect of the microinjection of dsRNA AntgCHS2.3 (SEQ ID No 6) on the survival of females of A. grandis. In the treatments, each insect was microinjected with 200 ng of dsRNA GUS (control) and 200 ng of dsRNA AntgCHS2.3.

DETAILED DESCRIPTION OF THE INVENTION

(14) The present invention describes methods and compositions for controlling pests, especially cotton-plant pests. For instance, the present invention provides recombinant DNA technologies for repressing or inhibiting post-transcriptionally the expression of a target sequence in the cell of a pest. This effect is achieved by feeding to one or more pests double-strain RNA or fragments of RNA (miRNA) or siRNA) transcribed from the whole target coding sequence of from a part thereof, thus controlling the infestation. As a result, the present invention relates to specific sequences of inhibition of the expression of coding sequences, using double-strain RNA (dsRNA), including little interfering RNA (siRNA), to achieve the desired levels of pest control.

(15) The present invention provides a method of inhibiting the expression of a target gene in coleoptera. In certain embodiments, the method comprises modulating or inhibiting the expression of one or more target-gene of coleoptera that brings about the inhibition of development, reproduction and/infectivity and possibly results in death of the insect. More specifically, the present invention relates to inhibition of the genes of the family of chitin synthase ion coleoptera, resulting in the interruption of the development and malformation of insects, both larvae and adults, and may result in death of the insect. The method comprises introducing double-stranded RNA (dsRNA) in a partial manner, stabilizing, including the modified forms thereof, such as small interfering RNA sequence (siRNA), in the cells or in an extracellular medium, such as the middle intestine, within coleoptera in which the dsRNA gets into the cell and inhibits the expression of at least one or mare target genes, and where the inhibition exerts a deleterious effect on the pest. The methods and the associated compositions can be used for limiting or eliminating the infestation of coleoptera or any pest host, symbiont pest, or environment in which the pest is present through one or more compositions that comprise the dsRNA molecule described herein in the diet of the pests.

(16) The present invention further provides examples of nucleic acid compositions that are homologous to at least one portion of the sequences selected from the group consisting SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof. A specific example of such nucleic acids provided by the invention is described in the SEQ ID NO 2 e SEQ ID NO 6 or complements thereof.

(17) In a further embodiment, the invention provides a method for suppressing the expression of the gene of a coleopteran pest, such as bicudo-do-algodoeiro (boll weevil) or of related species, which comprises the step of providing, in the diet of the pest, a gene suppressing amount of at least one dsRNA molecule transcribed from a nucleotide sequence, such as described herein, at least one segment of which is complementary to a miRNA sequence in the cell of the pest. The method further comprises death, dwarfishness, or cessation of feeding of the pest. A dsRNA molecule, including its modified form such as a siRNA molecule, fed to a pest according to the invention, may be of at least about 80, 81, 82, 83, 84, 85, 86, 87, 88 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or about 100% of identity with an RNA molecule transcribed from the sequences selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 e SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof.

(18) The present invention further provides a stabilized dsRNA molecule or the expression of one or more MiRNAs for inhibition of the expression of a target gene in a coleopteran pest expressed from this sequence and the fragments thereof. A stabilized sRNA, including an siRNA, miRNA molecule, or comprising at least two coding sequences that are arranged in one sense and the antisense orientation with respect to at least one promoter, wherein the nucleotide sequence that comprises a chain with sense and an antisense one is related or linked by a spacing sequence of at least from about thereto about ten Thousand nucleotides, wherein the chain with sense and the antisense chain may be formed of different lengths, and each of the two parts encodes sequences of at least 80% of sequence identity, at least 90%, at least 95%, at least 98%, or 100% of sequence identity to any sequence of one or more nucleotide (s) according to the sequences selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof.

(19) Besides, the invention further provides a fragment or concatamer of a nucleic acid sequence selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof. The fragment can be defined as causing death or preventing the development of a harmful organism when expressed as a dsRNA and supplied to the pest. For instance, the fragment may comprise at least about 19, 21, 23, 25, 40, 60, 80, 100, 125 or more contiguous nucleotides of the sequences selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 e SEQ ID No 4, SEQ ID No 5 e SEQ ID No 6, or fragments or complements thereof, or one complement thereof, A beneficial DNA segment for use in the present invention is at least 19 to about 23, or about 23 to about 100 nucleotides, up to about 2000 nucleotides in length or more. Particularly useful for the present invention are the DNA sequences including about 19 to about 400 nucleotides homologous to a target sequence of pests. The invention also provides a ribonucleic acid expressed from any of such sequences, including a dsRNA. The sequence selected for use in the expression of a gene suppressing agent may be constituted from a single sequence derived from one or more target pests and intended to be used in the expression of an RNA that functions in suppressing a single gene or a family of genes in one or more target pest, or the DNA sequence may be constituted as a chimera of a plurality of DNA sequences. Specifically for the present invention, this Family of genes is related to the Family of the genes of chitin synthase, specifically to chitin synthase 1 and chitin synthase 2.

(20) In a further embodiment, the invention provides recombinant DNA constructs comprising a nucleic acid molecule that encodes a dsRNA molecule described herein. The dsRNA may be formed by a transcription strand of the molecule of a nucleotide sequence that is at least about 80% to about 100% identical to the sequences selected from the groups consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof. Such recombinant DNA constructs can be defined as the production of dsRNA molecules, capable of inhibiting or reducing the expression of the endogenous target gene in a pest cell after ingestion. The construct may include a nucleotide sequence of the invention operatively linked to a promoter sequence that functions in the host cell. The present invention may make use of tissue-specific or constitutive promoters. Preferably for the present invention, the tissue-specific promoters may be, but are not limited to promoters specific for flower buds of cotton plants.

(21) Nucleic acid constructs according to the invention may comprise at least one nucleotide sequence that does not occur naturally and that may be transcribed in single-strand RNA, capable of forming a dsRNA molecule in vivo by hybridization. Such dsRNA sequences may be supplied to the diet of a coleopteran pest to achieve the desired inhibition. Preferably for the present invention the dsRNA molecule is formed by nucleotide sequences substantially similar to the sequences selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof.

(22) A recombinant DNA sequence may contain sequences substantially similar to the sequences selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof. The dsRNAs may either express from constructs introduced into various different transformation events, or may be introduced into a single nucleic acid molecule. The dsRNAs may be expressed by using a single promoter or multiple promoters. In an embodiment, the invention enables a recombinant host cell to have in its genome at least one recombinant DNA sequence that is transcribed to produce at least one dsRNA molecule, which functions when ingested by a coleopteran pest to inhibit or reduce the expression of a target gene in a pest. The dsRNA molecule may be encoded by the sequences selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof. The present invention also provides a transformed plant cell having in its genome at least one recombinant DNA sequence described herein. The transgenic plants that comprise such a transformed plant cell are also provided, including the progeny plants of any generation, seeds, and plant products, each comprising the recombinant DNA.

(23) The methods and compositions of the present invention may be applied to any monocotyledonous and dicotyledonous plant, depending on the desired control of coleopteran pests. Thus, the present invention describes a transformed plant with a recombinant DNA sequence, as described in the sequences selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, fragments or concatamers or complements thereof, which is transcribed to produce at least one dsRNA molecule, which functions when ingested by a coleopteran pest to inhibit or reduce the expression of a target gene.

(24) The invention also provides combinations of methods and compositions for controlling infestations of coleopteran pests. One way of providing a dsRNA method as described herein for protection of plants against infestations of insects is in conjunction with one or more insecticidal agents that exhibit characteristics other than those exhibited by the dsRNA methods and compositions. For instance, one or more Bt proteins may be supplied to the diet of the pests of insects, in combination with one or more dsRNA, as described herein. The composition formulated for topical application or derived, using a transgenic approach, which combines the methods and the dsRNA combinations with Bt can be used for creating synergisms that were not known before in the art to control infestation of insects. One synergism is the reduction in the level of expression necessary to the dsRNA (s) or the Bt protein (s). When combined, the smallest effective dose of each of the agents for controlling pests may be used. One believes that the insecticidal Bt protein creates entrance pores, through which the dsRNA molecules are capable of penetrating more effectively the spaces away from the intestine of the pest of insects, or more effectively for cells in proximity of injuries created by the Bt protein, thus requiring smaller amount of Bt or dsRNA to achieve the desired result of insecticidal action or desired inhibition or suppression of a specific biologic function on the target pest.

(25) Therefore, the present invention provides a composition containing two or more different pesticidal agents that are toxic to the same pest or species of insects, wherein at least one of which comprises one dsRNA described herein. In certain embodiments, the second agent may be one selected from the group consisting of a patatin, an insecticidal protein of Bacillus thuringiensis, an insecticidal Xenorhabdus protein, an insecticidal Photorhabdus protein, an insecticidal Bacillus laterosporous, an insecticidal Bacillus sphaericus, enzymes of the family of chitinase and a lignin. An insecticidal Bacillus thuringiensis protein may be any one of a number of insecticidal proteins, including, but not limited to Cryl, Cry8, Cry10, Cry35 TIC851, CryET70, Cry225 TIC901, TIC1201, TIC407, TIC417, insecticidal protein CryET33 and binary CryET34, insecticidal binary protein CryET80 and CryET76, binary insecticidal protein TICIOO and TICIOI, insecticidal binary of protein PS 14961, insecticidal VIP protein, protein TIC900 or the like, or combinations of insecticidal proteins ET29 or ET37 with insecticidal proteins TIC810 or TIC812 and insecticidal chimeras of any of the proteins cited before.

(26) A ribonucleic acid that is supplied to the diet may be provided in an artificial diet formulated to meet the special nutritional needs for a determined pest. The may also be a transformed recombinant cell with a DNA sequence constructed for expression of the target agent, the RNA or the gene suppression agent. After injection of one or more cells transformed by the pest, the desired result is phenotypically observed, indicating that the agent was used for inhibiting or reducing the expression of a target nucleotide sequence that is inside the pest cells.

(27) A target gene can encode for suppressing an essential protein. For the present invention, the target gene is of the family of chitin synthase, the function of which is to constitute the cuticle, trachea, and chitin of the peritrophic membrane. Therefore, the inhibition or reduction of the expression of such a gene may affect essential functions for survival of the insect to be selected from the group of differentiation and development of the cuticle, formation of the egg, larval maturation, larval stage transition, purgation, digestion and assimilation of nutrients, protection against pathogens.

(28) Another aspect of the present invention is to provide a method for improving the yield of a plant subjected to infestation of pests of insects, which comprises the steps of: a) introducing a polynucleotide comprising a sequence substantially similar to the sequences selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements of these or concatamers in said plant, and b) cultivating the plant so as to enable expression of said characteristic. Commerce

(29) A further aspect of the invention is to provide products that are agronomically and commercially important and/or matter compositions, including, but not limited to livestock feed, base products, products and by-products that are intended to be used as food for human consumption or for use in the compositions, and products that are intended for human consumption, including, but not limited to cottonseed meal, cottonseed oil, cottonseed cakes, cotton feather, cotton fiber, cereals, and so on. Such compositions can be defined as containing a detectable amount of a nucleotide sequence established herein, and to they are also diagnose for any transgenic happening containing such nucleotide sequences. These products are useful at least because they are susceptible to being obtained from crops propagated with less organophosphated pesticides and, as a result, from the incorporation of the nucleotides of the present invention for controlling infestation of pests and coleoptera on plants. Such base goods and products can be produced from seeds produced from a transgenic plant, wherein the plant expresses RNA from one or more contiguous nucleotides of the present invention or nucleotides of one or more coleopteran pests and respective complements.

(30) A method of making a product of this type comprises obtaining a plant transformed with a polynucleotide comprising a sequence selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof, or concatamers thereof, and preparation of a base product from the plant or a part thereof, is also provided in the present invention. Besides, a method of producing human food or animal feed, which comprises obtaining a plant transformed with a polynucleotide comprising a sequence selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof, or concatamers thereof, and preparing the food or animal feed from said plant or a parte thereof is a further aspect of the invention.

(31) The invention also provides a means readable by computer, which has a registered sequence selected from the group consisting of SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, or fragments or complements thereof, or concatamer thereof, for use in a certain number of computer applications, including, but not limited to the DNA identity and search for similarity, identity and search of similarity of protein, characterizations of profiles of transcription, comparisons between genomes, and analysis of artificial hybridizing.

(32) In the context of this description, numberless terms will be used, and so they are better detailed hereinafter.

(33) The term nucleic acid refers to a big molecule, which may be a single strand or a double strand, composed of monomers (nucleotides), containing a sugar, a phosphate and a purine base or pyrimidine base. A nucleic acid fragment is a fraction of a given nucleic acid molecule. Complementarity refers to the specific pairing of purine and pyrimidine bases consisting of nucleic acids: pairs of adenine with thymine and pairs of guanine with cytosine. Then, the complement of a first nucleic acid fragment is complementary to the first nucleotide sequence.

(34) On more developed plants, deoxyribonucleic acid (DNA) is the genetic material, while ribonucleic acid (RNA) is involved in the transfer of the DNA information in proteins. A genome is the whole main part of the genetic material contained in a cell of an organism. The term nucleotide sequence refers to the nucleotide polymer sequences, forming a DNA or RNA strand, which may be single or double strand, optionally synthetics, non-natural or with altered nucleotide bases capable of incorporation into DNA or RNA polymers. The term oligomer refers to short nucleotide sequences, usually up to 100 bases in length. The term homologous to the link between the sequences of nucleotides having two nucleic acid molecules or between the sequences of amino acids of two protein molecules. The estimate of such homology is provided hybridizing DNA-DNA or RNA-RNA under stringency conditions as defined in the prior art (as mentioned in document US20030074685, Hames and Higgins, Ed. (1985) Nucleic Acid Hybridization, IRL Press, Oxford, U.K.); or by the comparison of similarity of sequences between two nucleic acid or protein molecules (as mentioned in document US20030074685, Needleman et al, J. Mol. Biol. (1970) 48:443-453).

(35) Gene refers to the nucleotide fragment that expresses a specific protein, including preceding regulatory sequences (non-translated region 5) and following ones (non-translated region 3) with respect to the coding region. Native gene refers to an isolated gene with its own regulatory sequence found in nature. Chimeric gene refers to the gene that comprises coding, regulatory and heterogeneous sequences not found in nature. The chimeric gene of the present invention comprises isolated nucleic acid molecules, in the sense or antisense orientation, linked operatively to active promoters. Genic constructs of the present invention may contain 1 or more chimeric genes and may or may not exhibit introns. Endogenous gene refers to the native gene usually found in its natural location in the genome and is not isolated. An exogenous gene refers to a gene that is not normally found in the host organism, but which is introduced by genic transfer. Pseudogene refers to a nucleotide sequence that does note code a functional enzyme.

(36) Coding sequence refers to the DNA sequence that codes a specific protein and excludes the non-coding sequence. An interrupted coding sequence means the sequence that acts as separator (for instance, one or more introns linked by junctions). An intron is a nucleotide sequence that is transcribed and the re-linkage of the mRNA within the cell, generating a mature mRNA that con be translated in a protein. Examples of introns include, but are not limited to intron pdk2, intron catalase of castor bean, intron Delta 12 desnaturase of cotton, Delta 12 desnaturase of Arabidopsis, intron ubiquitin of maize, intron of SV40, introns of the gene of malate synthase.

(37) RNA transcript refers to the product resulting from transcription catalyzed by RNA polymerase of a DNA sequence. When the RNA transcript is a perfect copy of the DNA sequence, it is referred to as being a primary transcript or it may be an RNA sequence derived from a post-transcriptional process of the primary transcript and is then referred to as being a mature transcript. Messenger RNA (mRNA) refers to the RNA that is without introns. Sense RNA refers to an RNA transcript that includes the mRNA. Antisense RNA refers to an RNA transcript that is complementary to all the parts of a primary transcript or mRNA and that can block the expression of a target gene through interference with the processing, transportation and/or translation of its primary transcript of mRNA. The complementarity of an antisense RNA may be any part of the specific genic transcript, that is, non-translated sequence 5, non-translated sequence 3, introns or coding sequence. Besides, the antisense RNA may contain ribozyme sequence regions that enhance the efficacy of the antisense RNA to block the genic expression. Ribozyme refers to the catalytic RNA and includes specific endoribonuclease sequences. DsRNA (double strain) refers to the clamp structure formed between the sequence of the mRNA or sense RNA, the sequence of a spacing region and the sequence of the antisense RNA. Spacing region refers to the nucleotide sequence that is not related to the sequence of the target gene, as a sequence of an intron.

(38) The term vector refers to a replicon, as a plasmid, phages or virus, in which other genic sequences or elements (be they of DNA or RNA) may be linked. Thus, the genes may be replicated together with the vector. Preferably, one of the vectors of interest of the present invention refers to phagemid. The term phagemid refers to a vector that contains sequence for replication in phage and in bacterium. This vector has characteristics that meet the specifications of the host cell, as well as selecting and promoting agents. The term recombinant vector results from the combination of a commercial vector with nucleic acid molecules of the present invention, operatively linked to a promoter of interest and a termination signal. Such vectors can be obtained commercially, including those supplied by Clontech Laboratories, Inc (Palo Alto, Calif.), Stratagene (La Jolla, Calif.), Invitrogen (Carlsbad, Calif.), New England Biolabs (Beverly, Mass.) and Promega (Madison, Wis.). A few examples of vectors used in the present invention, but not limited thereto, are the vectors of the series pCambia (BioForge Co.), pB1121 (Chen, Po-Yen; Wang, Chen-Kuen; Soong, Shaw-Ching; To, Kin-Ying. Complete sequence of the binary vector pB1121 and its application in cloning T-DNA insertion from transgenic plants. Molecular Breeding vol. 11 issue 4 May 2003. p. 287-293), pBSK (Addgene Co.), pGEM-T easy (Promega Corporation), pET101/D-TOPO (Invitrogen). The obtainment of recombinant vectors comprising promoters linked to nucleic acids is known in the art and can be found in Sambrook et al. (Sambrook, J., Russell, D. W., Molecular Cloning, A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press. 1989).

(39) Substantially similar or substantial similarity refers to fragments of nucleic acids in which changes in one or more nucleotide bases do not prevent the capability of the nucleic acid fragment from mediating the alteration of the gene expression by gene silencing through, for instance, the antisense technology, co-suppression or interference RNA (iRNA/RNAi). Substantially similar nucleic acid fragments of the present invention may also be characterized by the percentage of similarity of their nucleotide sequences with the nucleotide sequences of the nucleic acid fragments described herein (SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6), as determined by a few common algorithms employed in the prior art. The preferred nucleic acid fragments are those whose nucleotide sequences have at least about 40 or 45% of sequence identity, preferably about 50% or 55% sequence identity, more preferably about 60 or 65% sequence identity, more preferably about 70% or 75% sequence identity, more preferably about 80% or 85% sequence identity, still more preferably about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% sequence identity as compared to the reference sequence.

(40) One of the ways to form the dsRNA is that the nucleotide sequence of the target gene in the sense orientation, as well as a nucleotide sequence in the antisense orientation should be present in the DNA molecule, and there may or may not be a spacing region between the sense and antisense nucleotide sequences. The mentioned nucleotide sequences may be constituted by about 19 nt to 2000 nt or even about 5000 nucleotides or more, each having a total substantial sequence similarity with about 40% to 100%. The longer the sequence, the less stringency is required for total substantial sequence similarity. The fragments containing at least about 19 nucleotides should have preferably about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% sequence identity as compared to the reference sequence, with the possibility of having about 2 non-contiguous different nucleotides. Preferably, one uses fragments above 60 pb, more preferably fragments between 100 and 600 pb.

(41) In one of the aspects of the invention, the dsRNA molecule may comprise one or more regions having a substantial sequence similarity for the regions with at least about 19 consecutive nucleotides of the sense nucleotides of the target gene, defined as first region and one or more regions having a substantial sequence similarity for the regions with about 19 consecutive nucleotides of the complement of the sense nucleotides of the target gene, defined as second region, wherein these regions may have pairs of bases separating them from each other.

(42) Conveniently, the dsRNA (double-stranded DNA) as described may be introduced into host cells by introducing and possibly integrating a gene construct containing the nucleic acid molecules of the present invention, transcription thereof for the production of the dsRNA. Therefore, in another embodiment the invention is also supported by having a gene construct that is capable of being expressed in eukaryotic organisms of interest, operatively linked to a DNA molecule that, when transcribed, produces a dsRNA molecule comprising a first region and a second region, wherein: (a) the first region comprises a nucleotide sequence of at least about 19 consecutive nucleotides having a substantial sequence similarity with at least about 19 consecutive nucleotides of the sequence of sense nucleotides of the target gene. (b) the second region comprises a nucleotide sequence of about at least 19 consecutive nucleotides having a substantial sequence similarity with the complement of about at least 19 consecutive nucleotides of the sequence of sense nucleotides of the target gene; (c) the first and the second regions are capable of forming a double-stranded RNA region, which may have, in addition to the total length of the first and of the second regions, a spacing region between them containing at least about 3 nucleotides.

(43) Promoter refers to the DNA sequence in a gene, usually located upstream of the coding sequence, which controls the expression of the coding sequence, promoting the recognizance of the RNA polymerase sequence and other factors required for the transcription itself. In an artificial DNA construct, promoters may also be used for transcribing dsRNA. Promoters may also contain DNA sequences that are involved in linking protein factors which control the effect of the transcription start in response to physiologic conditions or development conditions.

(44) In one of the aspects of the invention, the promoter is a constitutive promoter. In another aspect of the invention, the activity of the promoter is stimulated by external or internal factors such as, but not limited to hormones, chemical compounds, mechanical impulses, and conditions of biotic or abiotic stress. The activity of the promoter may also be regulated in a temporal and special manner (as for instance, tissue-specific promoters and promoters regulated during the development).

(45) The promoter may contain enhancers elements. An enhancer is a DNA sequence that can stimulate promoter activity. It may be an innate element of the promoter or a heterologous element inserted for raising the level and/or the tissue-specificity of a promoter. Consecutive promoters refer to those that direct the gene expression in all of the tissues and all the time. Tissue-specific promoters or development-specific promoters are those that direct the gene expression almost exclusively in specific tissues, such as leaves, roots, stems, flowers, fruits or seeds, or in specific development stages in a tissue, as in the beginning or in the end of embryogenesis. The term Expression refers to the transcription and stable accumulation of the dsRNA derived from the nucleic acid fragments of the present invention, which, in conjunction of the protein production apparatus of the cell, results in altered levels of mio-inositol 1-phosphate synthase. Inhibition by interference refers to the production of dsRNA transcripts capable of preventing the expression of the target protein.

(46) Suitable regulatory sequences refer to the nucleotide sequences in native or chimeric genes that are located above (non-translated region 5), within, and/or below (non-translated region 3) of the nucleic acid fragments of the invention, which control the expression of the nucleic acid fragments of the invention.

(47) Altered levels refer to the production of gene products in transgenic organisms in amounts or proportions that differ from those in normal or non-transgenic organisms. The present invention also reports vectors that include sequence of the gene of the chitin synthase 1 and 2 enzymes in sense and antisense orientation, and host cells, which are genetically engineered with vectors of the invention. Transformation refers to the transfer of the exogenous gene into the genome of a host organism and its genetically stable heritage.

(48) Plants refer to photosynthetic organisms, both eukaryotic and prokaryotic, wherein the term developed plants refer to eukaryotic plants. The nucleic acids of the invention may be used to impart desired tracts in essentially any plant. Then, the invention has use on various species of plants, including species of the genera: Anacardium, Anona, Arachis, Artocarpus, Asparagus, Atropa, Avena, Brassica, Carica, Citrus, Citrullus, Capsicum, Carthamus, Cocos, Coffea, Cucumis, Cucurbita, Daucus, Elaeis, Fragaria, Glycine, Gossypium, Helianthus, Heterocallis, Hordeum, Hyoseyamus, Lactuca, Linum, Lolium, Lupinus, Lycopersicon, Malus, Manihot, Majorana, Medicago, Nicotiana, Olea, Oryza, Panieum, Pannesetum, Passiflora, Persea, Phaseolus, Pistachia, Pisum, Pyrus, Prunus, Psidium, Raphanus, Ricinus, Secale, Senecio, Sinapis, Solanum, Sorghum, Theobromus, Trigonella, Triticum, Vicia, Vitis, Vigna, and Zea.

(49) In one of the aspects of the invention, the promoter is a promoter expressed in plants. As used herein, the term promoter expressed in plants means a DNA sequence that is capable of initiating and/or controlling the transcription of a plant cell. This includes any promoter of plant origin; any promoter of non-plant origin which is capable of directing the expression. In a plant cell, for instance, promoters of viral or bacterial origin such as CaMV35S (as mentioned in patent application US20030175783, Hapster et al, 1988 Mol. Gen. Genet. 212, 182-190) and promoter of the gene present in the T-DNA of Agrobacterium; tissue-specific or organ-specific promoters, including, but not limited to seed-specific promoters, (WO8903887), organ-primordia-specific promoters (as mentioned in patent application US20030175783, An et al., 1996 The Plant Cell 8, 15-30), stem-specific promoters (as mentioned in patent application US20030175783, Keller et al., 1988 EMBO J. 7: 3625-3633), leaf-specific promoters (as mentioned in patent application US20030175783, Hudspeth et al., 1989 Plant Mol Biol 12:579-589), mesophyle-specific promoters, root-specific promoters (as mentioned in patent application US20030175783, Keller et al., 1989 Genes Devel. 3:1639-1646), tuber-specific promoters (as mentioned in patent application US20030175783, Keil et al., 1989 EMBO J. 8: 1323:1330), vascular-tissue-specific promoters (a mentioned in patent application US20030175783, Peleman et al., 1989 Gene 84: 359-369), stamen-specific promoters (WO8910396, WO9213956), dehiscence zone-specific promoter (WO9713865); and the like.

(50) The termination signal of the transcription and the polyadenylation region of the present invention includes, but is not limited to SV40 termination signal, HSV TK termination signal of the gene of nopalin synthase of Agrobacterium tumefasciens (nos), termination signal of the gene RNA 35S do CaMV, termination signal of the virus that attacks Trifolium subterranean (SCSV), termination signal of the gene trpC of Aspergillus nidulans, and other similar ones.

(51) The present invention also includes providing dsRNA molecules, which can be obtained by transcription of the molecules contained in the gene constructs, that which are useful for the methods according to the invention.

(52) Another objective of the present invention is to provide eukaryotic cells, eukaryotic organisms containing dsRNA molecules of the invention, or containing the chimeric genes or the gene constructs capable of producing dsRNA molecules of the invention. The gen constructs may be stably integrated in the genome of the cells of eukaryotic organisms.

(53) In another aspect of the invention, the gene constructs may be provided in a DNA molecule capable of replicating in an autonomous manner in the cells of eukaryotic organisms, such as viral vector. The gene construct or the dsRNA may also be arranged in a transient way in the cells of eukaryotic organisms.

(54) The gene constructs or chimeric gene of the invention may be introduced into the genome of the desired hos plant through a number of conventional techniques. For instance, one it can be introduced directly into the genomic DNA of the plant cell by using techniques such as electroporation and microinjection of protoplasts from plant cells, or the construct may be introduced directly into the plant tissue by using ballistic methods, such as bombardment of particles covered with DNA.

(55) Microinjection techniques are known from the prior art and are well described in the scientific and patent literature. The introduction of gene constructs by using precipitations of polyethylene glycol is described in Paszkowski et al. Embo J. 3:2717-2722, 1984 (as mentioned in patent application US20020152501). Electroporation techniques are described in From et al. Proc. Natl. Acad. Sci. USA 82:5824, 1985 (as mentioned in patent application US20020152501). Ballistic transformation techniques are described in Klein et al. Nature 327:70-73, 1987 (as mentioned in patent application US20020152501).

(56) Alternatively, the gene constructs may be combined with suitable flanked regions of T-DNA and introduced into host conventional vector Agrobacterium tumefasciens. The virulence function of the host Agrobacterium tumefasciens will direct the insertion of the gene constructs and adjacent marker into the DNA of the plant cell when the cell is infected by the bacterium. Transformation techniques mediated by Agrobacterium tumefasciens, including disarmament and the use of binary vectors, are well described in the scientific literature (as mentioned in patent application US 20020152501, Horsch et al. Science 233:496-498, 1984; and Fraley et al. Proc. Natl. Acad. Sci. USA 80:4803, 1983).

(57) Cells of transformed plants that are derived from any of the transformation techniques described above may be grown for regenerating a whole plant that has the transformed genotype and then the desired phenotype as the essence or reduction of the formation of chitin structures of coleoperous insects such as the cuticle and/or the peritropohic membrane. Such regeneration techniques rely on the handling of certain phytohormones in a medium of growth of tissue culture, typically containing a biocidal and/or herbicidal marker, which should be introduced together with the desired nucleotide sequence. Regeneration of plants from protoplast culture is described in Evans et al., Protoplasts Isolation and Culture, Handbook of Plant Cell Culture, pp. 124-176, MacMillilan Publishing Company, New York, 1983; and Binding, Regeneration of Plants, Plant Protoplasts, pp. 21-73, CRC Press, Boca Raton, 1985 (as mentioned in patent application US20020152501). The regeneration can be obtained through plant calli, explants, organs, or a part thereof. Such regeneration techniques are generally described in Klee et al., Ann. Ver. Of Plant Phys. 38:467-486, 1987 1985 (as mentioned in patent application US20020152501).

(58) Without restricting the invention to a particular mode of action, it is expected that the enzyme in eukaryotic cells responsible for generating small RNA molecules with about 21 dsRNA nucleotide (as DICER in Drosophila) can be saturated by including an excess of dsRNA sequences (that is, complementary RNA molecules) which are not related to the nucleotide sequence of the target gene or of the gene to be silenced.

(59) The natural variation in the post-transcriptional regulation of the expression of the target gene occurring between different lines of eukaryotic organisms comprising the same dsRNA molecule will be replaced by handling the gens silencing spectrum. This fact may take place by including the nucleotide sequences of extra dsRNA not related to the target gene, which are operatively linked to the dsRNA formed by the first and second regions.

(60) The embodiments of the present invention can be effective against a number of pests. For the purposes of the present invention, the pests include, but are not limited to insects, fungi, bacteria, nematodes, acarids, protozoan pathogen, animal parasites, and the like. Pests of particular interest are insect pests, particularly insect pests that cause significant damages to agricultural plants. By insect pests one understands insects and other similar pests such as the insects of the orders: Diptera, Hymenoptera, Lepidoptera, Mallophaga, Homoptera, Hemiptera, Orthroptera, Thysanoptera, Dermaptera, Isoptera, Anoplura, Siphonaptera, Trichoptera, etc., particularmente Coleoptera, especialmente Anthonomus grandis, Diabrotica virgifera, Tenebrio molitor, Tribolium castaneum, Phoracantha semipunctata, Lixus angustatus, Acanthoscelides obtectus and other coleoptera that cause damages to woods and agronomically important plants of the families: Scolytidae, Cerambycidae, Curculionidae and Bostrichida. Insect pests of the present invention of most cultivars include, but are not limited to: CornOstrinia nubilalis, Agrotis ipsilon, Helicoverpa zea, Spodoptera frugiperda, Diatraea grandiosella, Elasmopalpus lignosellus, Diatraea saccharalis, Diabrotica virgifera virgifera, Diabrotica longicomis barberi, Diabrotica undecimpunctata howardi, Melanotus spp., Cyclocephala borealis, Cyclocephala immaculata, Popillia japonica, Chaetocnema pulicaria, Sphenophorus maidis, Rhopalosiphum maidis, Anuraphis maidiradicis, Blissus leucopterus leucopterus, Melanoplus femurrubrum, Melanoplus sanguinipes, Hylemya platura, Agromyza parvicornis, Anaphothrips obscrurus, Solenopsis milesta, Tetranychus urticae; SorgoChilo partellus, Spodoptera frugiperda, Helicoverpa zea, Elasmopalpus lignosellus, Feltia subterranea, Phyllophaga crinita, Eleodes, Conoderus, e Aeolus spp., Oulema melanopus, Chaetocnema pulicaria, Sphenophorus maidis, Rhopalosiphum maidis, Sipha flava, Blissus leucopterus leucopterus, Contarinia sorghicola, Tetranychus cinnabarinus, Tetranychus urticae; WheatPseudaletia unipunctata, Spodoptera frugiperda, Elasmopalpus lignosellus, Agrotis orthogonia, Elasmopalpus lignosellus, Oulema melanopus, Hypera punctata, Diabrotica undecimpunctata howardi, Schizaphis graminum, Macrosiphum avenae, Melanoplus femurrubrum, Melanoplus differentialis, Melanoplus sanguinipes, Mayetiola destructor, Sitodiplosis mosellana, Meromyza americana, Hylemya coarctata, Frankliniella fusca, Cephus cinctus, Aceria tulipae; SunflowerCylindrocupturus adspersus, Smicronyx fulus, Smicronyx sordidus, Suleima helianthana, Homoeosoma electellum, Zygogramma exclamationis, Bothyrus gibbosus, Neolasioptera murtfeldtiana; CottonHeliothis virescens, lagarta-das-mas; Helicoverpa zea, ear-of-corn caterpillar; Spodoptera exigua, Spodoptera frugiperda caterpiller; Pectinophora gossypiella, pink ballworm; Anthonomus grandis, boll-weevil; Aphis gossypii, cotton-plant louse; Pseudatomoscelis seriatus, cotton leaping flea; Trialeurodes abutilonea, white fly Bemisia tabaci; Melanoplus femurrubrum, gafanhoto; Melanoplus differentialis, grasshopper; Thrips tabaci, tripes-do-fumo; Franklinkiella fusca, tripes; Tetranychus cinnabarinus, caro vermelho; Tetranychus urticae, striped acarid; RiceDiatraea saccharalis, Spodoptera frugiperda, Helicoverpa zea, Colaspis brunnea, Lissorhoptrus oryzophilus, Sitophilus oryzae, Nephotettix nigropictus, Blissus leucopterus leucopterus, Acrosternum hilare; SoybeanPseudoplusia includens, Anticarsia gemmatalis, Plathypena scabra, Ostrinia nubilalis, Agrotis ipsilon, Spodoptera exigua, Heliothis virescens, Helicoverpa zea, Epilachna varivestis, Myzus persicae, Empoasca fabae, Acrosternum hilare, Melanoplus femurrubrum, Melanoplus differentialis, Hylemya platura, Sericothrips variabilis, Thrips tabaci, Tetranychus turkestani, Tetranychus urticae; BarleyOstrinia nubilalis, Agrotis ipsilon, Schizaphis graminum, Blissus leucopterus leucopterus; Acrosternum hilare, Euschistus servus, Jylemya platura, Mayetiola destructor, Petrobia latens; CanolaVrevicoryne brassicae, Phyllotreta cruciferae, Phyllotreta striolata, Phyllotreta nemorum, Meligethes aeneus, Meligethes rufimanus, Meligethes nigrescens, Meligethes canadianus, and Meligethes viridescens; PotatoLeptinotarsa decemlineata.

EXAMPLES

(61) The present invention is further defined in the following Examples. One should understand that these Examples, while indicating a part of the invention, are given illustratively only, without being limitative of the scope of the present inventions.

(62) Usual techniques of molecular biology such as transformation of bacteria and gel electrophoresis of agarose of nucleic acids are referred to by common terms to describe them. Details of the practice of these techniques, well known from the prior art, are described Sambrook, et al. (Molecular Cloning, A Laboratory Manual, 2nd ed. (1989), Cold Spring Harbor Laboratory Press). Various solutions used in experimental handling are referred-to by their common names such as lysis solution, SSC, SDS, etc. The compositions of these solutions can be found in reference Sambrook, et al. (supracitada).

Example 1Identification of Nucleotide Sequence of the Enzymes Chitin Synthase 1 and Chitin Synthase 2 of Anthonomus grandis for Preparing the dsRNA

(63) Eggs, larvae and adult insects of A. grandis were obtained from the Laboratrio de bioecologia e semioqumicos de insetos da Embrapa Recursos Genticos e Biotecnologia em Braslia-DF. The colony was fed with artificial diet as described by Monnerat et al (MONNERAT, R. G., et al., Criao massal do bicudo do algodoeiro Anthonomus grandis em laboratrio. Comunicado Tcnico, 46, Embrapa-Cenargen: Braslia, 2000), and kept at 262 C., relative humidity of 6010% and photophase of 12 hours.

(64) For cloning and sequencing of chitin synthase 1 and chitin synthase 2 of A. grandis the total RNA was isolated from eggs, larvae and adult insects by using Trizol (Invitrogen), the protocol indicated by the manufacturer. The cDNA was synthesized from 5 g de RNA total using the kit Superscript II First-Strand Synthesis System for RT-PCR (Invitrogen) using oligo NV-d(T)30-AP (Tabela I). For initial amplification of segments of chitin synthase 1 and chitin synthase 2 of A. grandis, one used degenerated primers corresponding to conserved regions found in catalytic domains of chitins synthases of other insects. One carried out two consecutive stapes of PCR using degenerated primers. The first PCR step consisted of amplifying the segment in the catalytic domain between the preserved amino acids DPDYYEFE (SEQ ID NO: 7) and LHPQE (SEQ ID NO: 8), using degenerated oligonucleotides for the sense primer oligonucleotide and for the antisense primer. The PCR conditions in this first step were as follows: 1 L diluted cDNA (1:20), 2.0 L buffer 10 High Fidelity, 0.8 L MgSO.sub.4 (50 mM), 0.4 L dNTP (10 mM), 0.4 L of each oligonucleotide (10 M), 0.2 L (1 U) Taq Platinum High Fidelity (Invitrogen) and 14.8 L H.sub.2O. In the second step, one used as a mold the product of the first step 1:20 and used primer oligonucleotides between the DGDIDF (SEQ ID NO: 9) regions (sense primer) and QYDQGEDRW (SEQ ID NO: 10) or GPGTIFLM (SEQ ID NO: 11) (antisense primer). In the two steps the PCR reactions with the degenerated primers were carried out using the following conditions: 94 C. for 3 minutes, followed by 30 cycles of 94 C. for 30 seconds, 48 C. for 30 seconds and extension at 72 C. for 1 minute.

(65) In order to obtain the complete cDNA sequence of chitin synthases, the ends 5 and 3 were amplified using specific oligonucleotides designed from the preserved region sequenced previously. FIG. 1 illustrates the steps of cloning the cDNA of AntgCHS1 synthesized from the do RNA extracted from eggs of A. grandis. The oligonucleotides used in the cloning steps of AntgCHS1 are listed in Table I. On the other hand, FIG. 2 illustrates the steps of cloning the cDNA of AntgCHS2 synthesized from the RNA synthesized from larvae and adults of A. grandis. The oligonucleotides used in the steps of cloning AntgCHS2 are listed in Table II. The complete sequence of the cDNA of AntgCHS1 SEQ ID No 1 and of the cDNA of AntgCHS2 SEQ ID No 3 was obtained by overlapping the fragments obtained by the 5 and 3 RACE.

(66) TABLE-US-00001 TABLEI ListofoligonucleotidesusedincloningAntgCHS1 Noofthe Nameofthe fragment Size Oligonucleotide oligonucleotide (FIG.1) (pb) Direction Type Sequence(5-3) NV-d(T)30-AP A D GAATTCACGCGTCGACTAG TAGCATATGTAC(T).sub.30VN (SEQIDNO:12) QuiSyntFor2010-DPD 1268 S D GAYCCNGAYTAYTAYGART TYGAR (SEQIDNO:13) QuiSyntRev3270-LHP A D YTCYTGNGGRTGNA (SEQIDNO:14) QuiSyntFor2400-DGD 1 588 S D GAYGGNGAYATYGAYTTY (SEQIDNO:15) QuiSyntRev2960-GPG A D CATVAGGAADATVGTDCCG GGDCCMAR (SEQIDNO:16) 5CHS1fw 2 2530 S E TTAATCGTTGTGGATATTT AATAG (SEQIDNO:17) AntgCHS1cons A E GAAAAACATCCGGGACTAC ervadorv ACAGTACGCA (SEQIDNO:18) AntgCHS1cons 2675 S E CGGGGATATTGATTTCCAA ervadofw CC (SEQIDNO:19) AgQS1GTWc12 3 A E TGACTTACACCAACTTATC 219rv C (SEQIDNO:20)

(67) TABLE-US-00002 TABLEII ListofoligonucleotidesusedincloningAntgCHS2 Noofthe Nameofthe fragment Size Oligonucleotide oligonucleotide (FIG.1) (pb) Direction Type Sequence(5-3) NV-d(T)30-AP A D GAATTCACGCGTCGACTAG TAGCATATGTAC(T)30VN (SEQIDNO:12) QuiSyntFor2010-DPD S D GAYCCNGAYTAYTAYGART TYGAR (SEQIDNO:13) QuiSyntRev3270-LHP 1268 A D YTCYTGNGGRTGNA (SEQIDNO:14) QuiSyntFor2400-DGD S D GAYGGNGAYATYGAYTTY (SEQIDNO:15) QuiSyntRev2700-QYD 1 324 A D CCANCKRTCYTCNCCYTGR TCRTAYTG (SEQIDNO:21) 5-1AntgCHS2fw 2 2601 S E CAAATTTCTCAAAAATCGC CACC (SEQIDNO:22) AntgCHS2conserv A E AACATGAGAAATATCGTTC adorv C (SEQIDNO:23) 5-2AntgCHS2fw 731 S E GGGATTTTGAAATCATACT TGGTA (SEQIDNO:24) AntgCHS2-c8194-Rv 3 A E GCGAGCATCAAAAACCATA TCC (SEQIDNO:25) AgQSconservadofw 4 2450 S E CGGGGATATTGATTTCCAA CC (SEQIDNO:19) GTW-AP A E TCCGAATTCACGCGTCGAC TAGTAGCA (SEQIDNO:26)

(68) The design of the double-stranded RNA segment consisted in choosing fragments between 180 pb and 600 pb, (SEQ ID No 2, SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6) by using, as a mold, the sequences of the cDNA AntgCHS1 and AntgCHS2. For the design of double-stranded RNA one used the program BLOCK-iT RNAi Designer (available at rnaidesigner.invitrogen.com/rnaiexpress), which analyzes the sequences and indicates regions of greater probability for use in gene silencing.

(69) The DNA molds for the synthesis of the double-stranded DNA (dsRNA), by in vitro transcription were synthesized by PCR, the oligonucleotide sequences are listed in Table III. The selected target regions of the cDNA were amplified through PCR reactions using specific primers flanked by the minimum sequence of the promoter T7 (5-TAATACGACTCACTATAGGGAGA (SEQ ID NO: 27)) using the following conditions: 94 C. for 3 minutes, followed by 30 cycles of 94 C. for 30 seconds 60 C. for 30 seconds and extension at 72 C. for 1 minute. After amplification, the PCR products were cloned on the vector pGEM-T-easy for confirmation of the target sequence by sequencing. The PCR products of the target sequences obtained and sequenced without the regions of the sequence of the promoter T7 are described in the sequences SEQ ID No 2, SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6. The detailing of the sequences SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6 is described in Example 4.

(70) TABLE-US-00003 TABLEIII OligonucleotidesusedinthePCRreactionsfor synthesisofthemoldsforinvitrotranscriptionofdsRNA Identification ofthe Nameofthe amplicom oligonucleotide Sequenceoftheoligonucleotide(5-3) (pb) AntgCHS1-dsRNAfw TAATACGACTCACTATAGGGAGAATCACAGGAGCAGCGTTGC SEQIDNo2 (SEQIDNO:28) AntgCHS1-dsRNArv TAATACGACTCACTATAGGGAGAACACCAACTTATCCAATATC (SEQIDNO:29) AntgCHS2.1-dsRNAfw TAATACGACTCACTATAGGGAGATCAAATTTCTCAAAATCG SEQIDNo4 (SEQIDNO:30) AntgCHS2.1-dsRNArv TAATACGACTCACTATAGGGAGAGCGAGCATCAAAAACCATATC (SEQIDNO:31) AntgCHS2.2-dsRNAfw TAATACGACTCACTATAGGGAGACGGAGACATCGATTTCCAAC SEQIDNo5 (SEQIDNO:32) AntgCHS2.2-dsRNArv TAATACGACTCACTATAGGGAGAAACATGAGAAATATCGTTCC (SEQIDNO:33) AntgCHS2.3-dsRNAfw TAATACGACTCACTATAGGGAGAAAGTAGACGCTCACGTATCC SEQIDNo6 (SEQIDNO:34) AntgCHS2.3-dsRNArv TAATACGACTCACTATAGGGAGATCTTCTGTGAATTGCTGCC (SEQIDNO:35) GusEC-dsRNAFw TAATACGACTCACTATAGGGAGAGAACTGAACTGGCAGACTATC Negative (SEQIDNO:36) GusEC-dsRNARv TAATACGACTCACTATAGGGAGAGCGGGTAGATATCACACTCTGT control (SEQIDNO:37)

(71) After confirmation of the mold sequence, the synthesis of dsRNA was carried out using 0.5 g of the PCR product of the sequences SEQ ID No 2, SEQ ID No 4, SEQ ID No 5 and SEQ ID No 6, flanked with the promoter region of the RNA polymerase of the T7, as a mold for a volume of transcription reaction of 20 L, as described in the protocol of the manual of the kit MEGAscript T7 High Yield (Ambion), the reaction contained 7.5 mM of each ribonucleotide ATP, CTP, GTP and UTP, buffer 1 and 50 U of T7 RNA polymerase.

(72) The reaction was incubated for 16 hours at 37 C., followed by treatment with DNAse I for 15 minutes. For alignment of the double-stranded RNA, the reaction products were incubated at 70 for 5 minutes and cooled at room temperature (22 C.). For purification of the transcription products, one carried out extraction with phenol/chloroform and subsequent precipitation with isopropyl alcohol, as according to protocol described by the manufacturer of the kit MEGAscript T7 High Yield (Ambion). The dsRNA was dissolved in water treated with DEPC. The integrity of the dsRNA was evaluated by gel electrophoresis of 1% agarose and the quantification was obtained by spectrophotomemetry. The final concentration of each dsRNA was adjusted to 200 ng/L to be used in the microinjection assays for evaluation of the gene silencing.

Example 2Bioassays of Microinjection of dsRNA in Anthonomus grandis

(73) Quantified samples of double-stranded RNA (dsRNA) were used in bioassays against the boll-weevil. The dsRNA was prepared from sequences identified as described in Example 1. For the procedure of microinjection in A. grandis adult insects and larvae were previously anesthetized in ice for 10 minutes. The microinjection was carried out by using a syringe Hamilton de 10 L, on each infects one applied 1 L of aqueous solution contain or not containing the dsRNA. The injection to the larva was carried out in the dorsal region between the fourth and the fifth abdominal segment. In the adult insects there was a need to raise one of the elytra to expose the abdomen, site of the microinjection. After the injection, the insects were: 1) kept in standard feeding conditions on artificial diet as described by Monnerat et al (MONNERAT, R. G., et al., Criao massal do bicudo do algodoeiro Anthonomus grandis em laboratrio. Comunicado Tcnico, 46, Embrapa-Cenargen: Braslia, 2000); 2) withdrawn when necessary according to the experimental period; 3) frozen in liquid nitrogen and stocked at 80 C. until the momento f extraction of the total RNA.

Example 3Bioassays of Microinjection of dsRNA in Anthonomus grandis for Functional Analysis of AntgCHS1

(74) The evaluation of the silencing of AntgCHS1 on phenotype parameters of females of A. grandis was determined by bioassays of microinjection of dsRNA AntgCHS1 (SEQ ID No 2) in adult females. The quantified phenotype parameters were oviposition, viability of eggs and mortality of the adult insect. Each experimental unit consisted of 16 adult females with 48 hours of age microinjected with 200 ng of dsRNA and 8 non-microinjected adult male insects the experimental period was of 12 days. The insects were kept in small cages, where the cage floor was made from fabric to enable collection of eggs. The male insects were marked with silvery glitter to facilitate identification. The monitoring of the bioassay was made every 48 hours, a moment when water and artificial diet were offered to ad libitum. The bioassay consisted of three biological replicas with three technical replicas. The control treatment consisted in applying dsRNA of a non-related gene, in this case one used dsRNA with sequence of the gene gus of Escherichia coli. In order to analyze the data obtained in the bioassays, one applied a variance analysis, followed by the Tukey multiple comparison test, at the level of 5% of significance. The eggs obtained from this experiment were subjected to analysis of the expression of AntgCHS1 by PCR in real time, as described in example 5.

(75) In order to evaluate the silencing effect AntgCHS1 on the formation of newborn larvae, eggs obtained from the silencing experiment described before were perforated mechanically with entomologic nippers to break the egg shell and enable eclosion of the larvae. The larvae were kept on artificial diet for seven days. After this period, the larvae were counted and the phenotypes were analyzed. The eggs of the control treatment (dsRNA GUS) were also subjected to the same process of perforating their shell.

(76) In order to analyze the biologic function of AntgCHS1 during the development of pupas of A. grandis, larvae of third instar were microinjected with 200 ng of dsRNA AntgCHS1. Each experimental unit consisted of 20 larvae. The bioassay consisted of three biologic replicas with three technical replicas. The experimental period was of 10 days. After this period, the larvae were counted and the phenotypes obtained were analyzed and photographed.

Example 4Bioassays of Microinjection of dsRNA AntgCHS2 in Anthonomus grandis for Functional Analysis of AntgCHS2

(77) In the microinjection assays with a view to the analysis of the silencing of enzyme chitin synthase 2 (AntgCHS2) one evaluated a number of variables as described hereinafter: 1influence of the size of the segment of dsRNA; 2location of the sequence of the target dsRNA within the sequence of the cDNA de AntgCHS2 (SEQ ID No 3); 3effect of the concentration of dsRNA microinjected; 4persistence of the silencing during the phases of development of the insect. The details of these experiments are described hereinafter.

(78) 1-Location of the Target Sequence within the Sequence of cDNA of AntgCHS2 and of the Size of the Segment of dsRNA for the Silencing:

(79) In order to evaluate the effect of the position of the target sequence within the sequence of the cDNA of AntgCHS2 for the silencing, one selected three regions for synthesis of the dsRNA: the dsRNA localized at the end 5, called AntgCHS2-1 (SEQ ID No 4), comprising the region between the nucleotides 425-638 of the cDNA of AntgCHS2; the dsRNA localized in the central region, called AntgCHS2-2 (SEQ ID No 5), comprising the region between the nucleotides 2379-2966 of the cDNA; and the dsRNA localized at the end 3, called AntgCHS2-3 (SEQ ID No 6), comprising the region between the nucleotides 4373-4557 do cDNA. The segments chosen for the analysis of the dsRNAs had the sizes of 213, 587 and 184 pairs of bases, respectively.

(80) In this assay one microinjected 200 ng of dsRNA per adult insect in a total of 12 insects. After 72 hours, four insects were selected at random, frozen in liquid nitrogen and kept at 80 C. The synthesis of the cDNAs of the different sizes, as well as the analysis by qRT-PCR, was carried out as described in example 5. One carried out two control treatments, one consisted in applying water treated with DEPC, and the other control consisted of microinjection of dsRNA GUS.

(81) 2Effect of the Microinjected Dose of dsRNA

(82) In order to evaluate the effect of the microinjected concentration of dsRNA on the silencing AntgCHS2, one tested the concentrations of 50, 100 and 200 ng of dsRNA AntCHSB-3/insect (SEQ ID No 6). This dsRNA was chosen from among the three available, since it is specific for A. grandis, and keep the size (184 pb), which reduced the possibility of the effect cross silencing with non-target genes. In this assay, a total of 12 adult insects were microinjected. After 72 hours, four insects were selected at random, frozen in liquid nitrogen and kept at 80 C. The synthesis of the cDNAs of different treatments, as well as the analysis by qRT-PCR, was carried out as described in example 5.

(83) 3Persistence of the Silencing During the Phases of Development of the Insect.

(84) Larvae were microinjected with dsRNA in order to evaluate the persistence of the effect of the RNAi on adult insect. Herein we adopt the nomenclature laRNAi (RNAi larval), suggested by Huvenne and Smagghe for this type of experiment (HUVENNE, H., et al., Mechanisms of dsRNA uptake in insects and potential of RNAi for pest control: A review. Journal of Insect Physiology, v. 56, n. 3. p. 227-235. 2010). The larvae of third instar of development were microinjected with 200 ng of dsRNA AntgCHS2-3 (SEQ ID No 6) and placed on artificial diet. Adult insects with age of 72 hours were subjected to the PCT analyses in real time, as described in example 5.

(85) The evaluation of the silencing of AntgCHS2 on phenotypic parameters of females of A. grandis was carried out by means of microinjection bioassays on adult females. The quantified phenotypic parameters were oviposition, viability of eggs and mortality of the adult insect. Each experimental unit consisted of 16 adult female insects with 48 hours of age microinjected with 200 ng of dsRNA and 8 non-microinjected adult male insects the experimental period was of 12 days. The insects were kept in small cages, where the cage floor was made from web to facilitate identification. The monitoring of the bioassay was carried every 48 hours, a moment when water and artificial diet were offered ad libitum. The bioassay consisted of three biologic replicas with three technical replicas. The control treatment consisted in applying dsRNA of a non-related gene; in this case, one used dsRNA with sequence of gus gene of E. coli. In order to analyze the data obtained in the bioassays one applied a variance analysis, followed by the Tukey multiple comparison test, at the level of 5% of significance.

Example 5Determination of the Levels of Expression of AntgCHS1 and AntgCHS2

(86) For evaluation of the effect of the dsRNA on the expression of the target transcript (AntgCHS1 and AntgCHS2), one used the qRT-PCR technique (real-time quantitative PCR) (KUBISTA, M., et al., The real-time polymerase chain reaction. Molecular aspects of medicine, v. 27, n. 2-3. p. 95-125. 2006). The total RNA of insects from each treatment was isolated by using Trizol (Invitrogen), followed by the protocol indicated by the manufacturer. The cDNA was synthesized by using the kit SuperScript III Reverse Transcriptase (Invitrogen) from 1 g of total RNA treated with Ambion DNAse I RNAse-Free (Invitrogen) using the oligonucleotide NV-d(T)30-AP (see Table I).

(87) The real-time PCR reaction was carried out on the equipment 7300 Real-Time PCR System (Applied Biosystems) using SYBR Green, as intercalation fluorophore. The sequences of the oligonucleotides used for evaluation of the transcripts are described on Table IV. Each reaction was carried out in 2 L of a dilution 1:20 of cDNA, 0.2 M of each oligonucleotide in a total volume of 10 L. The program for qRT-PCR consisted of a starting step at 95 C. for 10 minutes, followed by 40 cycles of 95 C. for 20 seconds, 60 C. for 30 seconds and 72 C. for 30 seconds. For analysis of the amplifications at Ct (cycle of the threshold) and the amplification effectiveness of each oligonucleotide (ranging from 90% a 100%) were finished by the program Real-time PCR Miner (www.miner.ewindup.info/) (ZHAO, S., et al., Comprehensive algorithm for quantitative real-time polymerase chain reaction. Journal of Computational Biology, v. 12, n. 8. p. 1047-1064. 2005). The analysis of the relative expression, based on the Cts values and using multiple genes was carried out on the program qBasePlus version 2.0 by the method of Pfaffl (PFAFFL, M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research, v. 29, n. 9. p. e45. 2001). All the qRT-PCR experiments were carried out on two biologic replicas and three technical repetitions. The genes GAPDH and beta-Actina were used as reference genes. The statistical analysis was carried out by the Tukey test, at the significance level of 0.05% for comparison with the treatments.

(88) TABLE-US-00004 TABLEIV OligonucleotidesusedinthePCRreactionsinrealtime foranalysisoftheexpressionofAntgCHS1andAntgCHS2 Sequenceof Sequenceof Size Name thesense theantisense ofthe ofthe oligonucleotide oligonucleotide amplicom Efficiency oligonucleotide (5-3) (5-3) (pb) (%) AntgCHS1-RT TGCTCCTGATAGATTTGATG ATCCGGGACTACACAGTACGCA 174 105 (SEQIDNO:38) (SEQIDNO:39) AntgCHS2-RT AAGGCATTAACGGTGACGAC TCCAAGTCGTTGATGACTGC 120 101 (SEQIDNO:40) (SEQIDNO:41) GAPDH-RT AGATCGTCGAGGGTCTGATG AAGGCGGGAATGACTTTACC 166 99 (SEQIDNO:42) (SEQIDNO:43) B-Actin-RT CCTTTAACACCCCTGCTATG TGAGGTAGTCGGTCAAGTCA 192 102 (SEQIDNO:44) (SEQIDNO:45)

Example 6Results of the Bioassays of Microinjection of dsRNA and Evaluation of the Gene Silencing for Enzyme Chitin Synthase 1 in A. Grandis (AntgCHS1)

(89) One identified the cDNA sequence of the gene of Chitin synthase 1 in 1 (or A) of A. grandis, the size of which was of 4831 nucleotides (SEQ ID NO 1). Within this sequence, one selected a region of 249 pb (SEQ ID NO 2) to serve as a mold for the analysis of the dsRNA molecule, as described in example 1.

(90) One verified by means of the microinjection bioassays that the dsRNA AntgCHS1 (SEQ ID NO 2) was capable of suppressing the number of transcripts of Chitin synthase 1 in eggs of A. grandis (FIG. 3). In assays of microinjection of the dsRNA AntgCHS1 in adults of A. grandis, it caused reduction of the viability of the eggs (FIG. 4). It was observed that that the larvae formed within the eggs and moved actively, but did not eclose (FIG. 4). Some of these unviable eggs were perforated mechanically with the aid of nippers to for eclosion of the larvae. The perforated eggs were put on artificial diet for the development of the larvae. The larvae from the treatment with dsRNA AntgCHS1 exhibited malformations in the cephalic capsule and of the mandibles, and one observed the total mortality of the eclosed larvae from the treatment with dsRNA AntgCHS1 (FIG. 5).

(91) In experiments of microinjection of dsRNA AntgCHS1 (SEQ ID NO 2) in last instar larvae, it was observed that all the silenced insects either did not manage to develop in pupa or died. Non-silenced insects developed normally and became adults (FIG. 6).

Example 7Results of the Bioassays of Microinjections of dsRNA and Functional Evaluation of the Gene Silencing for Enzyme Chitin Synthase 2 (AntgCHS2) in A. grandis

(92) On identified the sequence of cDNA of the gene of Chitin synthase 2 (or B) of Anthonomus grandis, the size of which was of 4729 nucleotides (SEQ ID NO 3). Within this sequence, one selected three regions of different sizes (SEQ ID NO 4, SEQ ID NO 5 and SEQ ID NO 6) to serve as mold for the synthesis of dsRNA molecules, as described in example. It was verified, by means of the microinjection bioassays and by the results of the real-time PCR analyses that dsRNAs of different sizes, ranging from 180 to 600 pb, were capable of suppressing the number of transcripts of AntgCHS2 without differing statistically between the treatments. In the same way, there was no difference between the regions chosen with target for the silencing, bit it at the end 5, in the central region, or still at the end 3 of cDNA (FIG. 7). Also, by real-time PCR analysis one observed that in adult insects microinjections of 50 ng of dsRNA were sufficient to cause a drastic reduction of the number of transcripts after 72 hours (FIG. 8). For the experiment of microinjection in larvae, the treatment that presented the greatest effect was the microinjection of 200 ng of dsRNA per insect (FIG. 9). It was verified that the effect of the gene silencing persists after the metamorphosis, that is, adults from microinjected larvae exhibited reduction of the number of transcripts of the chitin synthase 2 with respect to the control treatment (dsRNA GUS) (FIG. 10).

(93) In the evaluation of phenotypic parameters caused by microinjection of dsRNA AntgCHS2 (SEQ ID NO 6), it was found that, after 144 hours, the females microinjected with RNAi interrupted the oviposition, causing a reduction of 93% of the number of eggs (FIG. 11). Besides, the rate of mortality of the insects increased along the time, reaching 100% after 240 hours. On attributed to this lethal phenotype the initial interruption of the feeding that resulted in the interruption of the oviposition, followed by the death of the insect (FIG. 12).